A citation-based method for searching scientific literature

Nadine Dietrich, Matthias Kolibabka, Stephanie Busch, Petra Bugert, Ulrike Kaiser, Jihong Lin, Thomas Fleming, Michael Morcos, Thomas Klein, Andrea Schlotterer, Hans-Peter Hammes. PLoS One 2016
Times Cited: 31







List of co-cited articles
260 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Topical Administration of GLP-1 Receptor Agonists Prevents Retinal Neurodegeneration in Experimental Diabetes.
Cristina Hernández, Patricia Bogdanov, Lidia Corraliza, Marta García-Ramírez, Cristina Solà-Adell, José A Arranz, Ana I Arroba, Angela M Valverde, Rafael Simó. Diabetes 2016
105
38

Intravitreal injection of exendin-4 analogue protects retinal cells in early diabetic rats.
Yu Zhang, Jingfa Zhang, Qingping Wang, Xia Lei, Qing Chu, Guo-Tong Xu, Wen Ye. Invest Ophthalmol Vis Sci 2011
64
25

Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
Andreia Gonçalves, Catarina Marques, Ermelindo Leal, Carlos F Ribeiro, Flávio Reis, António F Ambrósio, Rosa Fernandes. Biochim Biophys Acta 2014
55
22


Topical administration of DPP-IV inhibitors prevents retinal neurodegeneration in experimental diabetes.
Cristina Hernández, Patricia Bogdanov, Cristina Solà-Adell, Joel Sampedro, Marta Valeri, Xavier Genís, Olga Simó-Servat, Marta García-Ramírez, Rafael Simó. Diabetologia 2017
42
22

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
19

Dipeptidyl Peptidase-4 Inhibitor Increases Vascular Leakage in Retina through VE-cadherin Phosphorylation.
Choon-Soo Lee, Yun Gi Kim, Hyun-Jai Cho, Jonghanne Park, Heewon Jeong, Sang-Eun Lee, Seung-Pyo Lee, Hyun-Jae Kang, Hyo-Soo Kim. Sci Rep 2016
34
16

Protective effects of the dipeptidyl peptidase IV inhibitor sitagliptin in the blood-retinal barrier in a type 2 diabetes animal model.
A Gonçalves, E Leal, A Paiva, E Teixeira Lemos, F Teixeira, C F Ribeiro, F Reis, A F Ambrósio, R Fernandes. Diabetes Obes Metab 2012
67
16


Diabetic retinopathy.
David A Antonetti, Ronald Klein, Thomas W Gardner. N Engl J Med 2012
937
16


The glucagon like peptide 1 analogue, exendin-4, attenuates oxidative stress-induced retinal cell death in early diabetic rats through promoting Sirt1 and Sirt3 expression.
Ying Zeng, Ke Yang, Fang Wang, Liping Zhou, Yong Hu, Meiling Tang, Shijia Zhang, Shuqing Jin, Jingfa Zhang, Juan Wang,[...]. Exp Eye Res 2016
33
16

The progress in understanding and treatment of diabetic retinopathy.
Alan W Stitt, Timothy M Curtis, Mei Chen, Reinhold J Medina, Gareth J McKay, Alicia Jenkins, Thomas A Gardiner, Timothy J Lyons, Hans-Peter Hammes, Rafael Simó,[...]. Prog Retin Eye Res 2016
348
12

Protection of exendin-4 analogue in early experimental diabetic retinopathy.
Yu Zhang, Qingping Wang, Jingfa Zhang, Xia Lei, Guo-Tong Xu, Wen Ye. Graefes Arch Clin Exp Ophthalmol 2009
44
12

Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives.
Rafael Simó, Cristina Hernández. Trends Endocrinol Metab 2014
250
12

Topical administration of somatostatin prevents retinal neurodegeneration in experimental diabetes.
Cristina Hernández, Marta García-Ramírez, Lidia Corraliza, Jimena Fernández-Carneado, Josep Farrera-Sinfreu, Berta Ponsati, Agueda González-Rodríguez, Angela M Valverde, Rafael Simó. Diabetes 2013
75
12

Protection of exenatide for retinal ganglion cells with different glucose concentrations.
Zheng Fu, Hong-Yu Kuang, Ming Hao, Xin-Yuan Gao, Yu Liu, Ning Shao. Peptides 2012
20
20

Beneficial effects of vildagliptin on retinal injury in obese type 2 diabetic rats.
Satoshi Maeda, Sho-ichi Yamagishi, Takanori Matsui, Sae Nakashima, Ayako Ojima, Sayaka Maeda, Yuri Nishino, Yuji Ishibashi, Yumiko Yoshida, Ryoji Yamakawa. Ophthalmic Res 2013
20
20

Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes.
Christian Ott, Ulrike Raff, Stephanie Schmidt, Iris Kistner, Stefanie Friedrich, Peter Bramlage, Joanna M Harazny, Roland E Schmieder. Cardiovasc Diabetol 2014
45
12

Retinal digest preparation: a method to study diabetic retinopathy.
Nadine Dietrich, Hans-Peter Hammes. Methods Mol Biol 2012
22
18

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
12

Glucagon-like peptide-1 receptor expression in the human eye.
Josephine B Hebsgaard, Charles Pyke, Emre Yildirim, Lotte B Knudsen, Steffen Heegaard, Peter H Kvist. Diabetes Obes Metab 2018
14
28

The impact of improved glycaemic control with GLP-1 receptor agonist therapy on diabetic retinopathy.
Lakshminarayanan Varadhan, Tracy Humphreys, Adrian B Walker, George I Varughese. Diabetes Res Clin Pract 2014
18
22

Effects of medical therapies on retinopathy progression in type 2 diabetes.
Emily Y Chew, Walter T Ambrosius, Matthew D Davis, Ronald P Danis, Sapna Gangaputra, Craig M Greven, Larry Hubbard, Barbara A Esser, James F Lovato, Letitia H Perdue,[...]. N Engl J Med 2010
740
12

Diabetic Retinopathy: A Position Statement by the American Diabetes Association.
Sharon D Solomon, Emily Chew, Elia J Duh, Lucia Sobrin, Jennifer K Sun, Brian L VanderBeek, Charles C Wykoff, Thomas W Gardner. Diabetes Care 2017
263
12


GLP-1 Treatment Improves Diabetic Retinopathy by Alleviating Autophagy through GLP-1R-ERK1/2-HDAC6 Signaling Pathway.
Xiangsheng Cai, Jingjing Li, Mingzhu Wang, Miaoqin She, Yongming Tang, Jinlong Li, Hongwei Li, Hongxiang Hui. Int J Med Sci 2017
28
14

The db/db mouse: a useful model for the study of diabetic retinal neurodegeneration.
Patricia Bogdanov, Lidia Corraliza, Josep A Villena, Andrea R Carvalho, José Garcia-Arumí, David Ramos, Jesús Ruberte, Rafael Simó, Cristina Hernández. PLoS One 2014
104
9

Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy.
M Garcia-Ramírez, C Hernández, M Villarroel, F Canals, M A Alonso, R Fortuny, L Masmiquel, A Navarro, J García-Arumí, R Simó. Diabetologia 2009
85
9


Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration.
Esther Carrasco, Cristina Hernández, Adela Miralles, Pere Huguet, Jaume Farrés, Rafael Simó. Diabetes Care 2007
118
9


Dicarbonyl Stress Mimics Diabetic Neurovascular Damage in the Retina.
M Kolibabka, P Friedrichs, N Dietrich, T Fleming, A Schlotterer, H-P Hammes. Exp Clin Endocrinol Diabetes 2016
5
60

Low-dose erythropoietin inhibits oxidative stress and early vascular changes in the experimental diabetic retina.
Q Wang, F Pfister, A Dorn-Beineke, F vom Hagen, J Lin, Y Feng, H P Hammes. Diabetologia 2010
41
9

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
9

Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice.
Carmel M McVicar, Micheal Ward, Liza M Colhoun, Jasenka Guduric-Fuchs, Angelika Bierhaus, Thomas Fleming, Andreas Schlotterer, Matthias Kolibabka, Hans-Peter Hammes, Mei Chen,[...]. Diabetologia 2015
44
9

Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010.
Janet L Leasher, Rupert R A Bourne, Seth R Flaxman, Jost B Jonas, Jill Keeffe, Kovin Naidoo, Konrad Pesudovs, Holly Price, Richard A White, Tien Y Wong,[...]. Diabetes Care 2016
227
9


Diabetic retinopathy: targeting vasoregression.
Hans-Peter Hammes, Yuxi Feng, Frederick Pfister, Michael Brownlee. Diabetes 2011
214
9

Beneficial effects of PKF275-055, a novel, selective, orally bioavailable, long-acting dipeptidyl peptidase IV inhibitor in streptozotocin-induced diabetic peripheral neuropathy.
R Bianchi, I Cervellini, C Porretta-Serapiglia, N Oggioni, B Burkey, P Ghezzi, G Cavaletti, G Lauria. J Pharmacol Exp Ther 2012
33
9

The Neuroprotection of Liraglutide Against Ischaemia-induced Apoptosis through the Activation of the PI3K/AKT and MAPK Pathways.
Huili Zhu, Yusheng Zhang, Zhongshan Shi, Dan Lu, Tingting Li, Yan Ding, Yiwen Ruan, Anding Xu. Sci Rep 2016
114
9


Incretin-based therapies for type 2 diabetes mellitus.
Julie A Lovshin, Daniel J Drucker. Nat Rev Endocrinol 2009
484
9

Neuroprotective effects of liraglutide for stroke model of rats.
Kenichiro Sato, Masahiro Kameda, Takao Yasuhara, Takashi Agari, Tanefumi Baba, Feifei Wang, Aiko Shinko, Takaaki Wakamori, Atsuhiko Toyoshima, Hayato Takeuchi,[...]. Int J Mol Sci 2013
79
9

Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
Yazhou Li, Miaad Bader, Ian Tamargo, Vardit Rubovitch, David Tweedie, Chaim G Pick, Nigel H Greig. J Neurochem 2015
57
9

Liraglutide protects against amyloid-β protein-induced impairment of spatial learning and memory in rats.
Wei-Na Han, Christian Hölscher, Li Yuan, Wei Yang, Xiao-Hui Wang, Mei-Na Wu, Jin-Shun Qi. Neurobiol Aging 2013
97
9



Exendin-4 Reverses Biochemical and Functional Alterations in the Blood-Brain and Blood-CSF Barriers in Diabetic Rats.
Caroline Zanotto, Fabrício Simão, Manuela Sangalli Gasparin, Regina Biasibetti, Lucas Silva Tortorelli, Patrícia Nardin, Carlos-Alberto Gonçalves. Mol Neurobiol 2017
16
18

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.
Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn,[...]. N Engl J Med 2015
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.